PPARA and metabolic dysfunction-associated steatotic liver disease: KEGG enrichment analysis indicated the involvement of candidate genes in lipid metabolism‐related pathways such as PPAR signaling pathway (hsa03320), lipid and atherosclerosis (hsa05417), nonalcoholic fatty liver disease (hsa04932), regulation of lipolysis in adipocytes (hsa04923), and arachidonic acid metabolism (hsa00590) (Table S2).